Loading clinical trials...
Loading clinical trials...
A 2-year phase 3, multicentre, randomised, parallel-group, sham-controlled, double-masked study. Primary efficacy will be determined at Week 52.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Opthea Limited
NCT07308639 · Neovascular Age-related Macular Degeneration (nAMD); Diabetic Macular Edema (DME); Retinal Vein Occlusion (RVO)
NCT06439576 · Diabetic Macular Edema, Neovascular Age-related Macular Degeneration, and more
NCT05562947 · Neovascular Age-related Macular Degeneration, nAMD
NCT05904028 · Neovascular Age-related Macular Degeneration
NCT07275840 · Neovascular Age-related Macular Degeneration
COAST Investigational Site
Phoenix, Arizona
COAST Investigational Site
Arcadia, California
COAST Investigational Site
Huntington Beach, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions